Načítá se...
Protection from Ataxia-linked Apoptosis by Gap Junction Inhibitors
Mutations in the protein kinase C γ (PKCγ) gene cause spinocerebellar ataxia type 14 (SCA14), a heterogeneous neurodegenerative disorder. Synthetic peptides (C1B1) serve as gap junction inhibitors through activation of PKCγ control of gap junctions. We investigated the neuroprotective potential of t...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2034346/ https://ncbi.nlm.nih.gov/pubmed/17822669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2007.08.093 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|